MARYNA HALL: Open Payments
NPI 1437650207 · SEA GIRT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 50 payments from 12 companies in 2025. Trend: 2023 $243 · 2024 $610 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $216 |
| Novo Nordisk Inc | 14 | $187 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 4 | $66 |
| Lilly USA, LLC | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| Corcept Therapeutics | 2 | $33 |
| IBSA Pharma Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, MOUNJARO, Rybelsus, FARXIGA, Ozempic, TZIELD, Korlym, Tirosint.
Industry payments across NJ — which companies pay providers there.
